Participant-centric Trial Will Test if Antiviral Paxlovid Can Help With Long COVID
Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID long-haulers and their providers.
Nasal Swabs Could Help Identify Emerging Viruses, Yale Researchers Say
The researchers are looking for little known viruses in certain samples to try to identify new diseases before they become a threat. “COVID came as a surprise. All of the sudden, there was an outbreak, and people discovered that there was a new virus that could cause an illness,” Dr. Ellen Foxman, Yale School of Medicine immunologist, said. “What we want to do going forward is be able to get ahead of that.”Source: NBC News CT
Long COVID: Skeptics Are Wrong, Researchers Say
WHRY collaborator Akiko Iwasaki, PhD, joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease. Listen to their discussion as part of "Conversations on Health Care."Source: Community Health Center
Competition between respiratory viruses may hold off a ‘tripledemic’ this winter
A growing body of evidence suggests that SARS-CoV-2 and other respiratory viruses often “interfere” with each other. Although waves of each virus may stress emergency rooms and intensive care units, the small clique of researchers who study these viral collisions say there is little chance the trio will peak together and collectively crash hospital systems the way COVID-19 did at the pandemic’s start.Source: Science
Will Long COVID Research Provide Answers for Poorly Understood Diseases Like ME/CFS?
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a highly disabling, severe condition that has been largely overlooked and even questioned as an illness by physicians and biomedical researchers for decades. But now, scientists including Yale's Akiko Iwasaki and Harlan Krumholz are finding parallels between post-infection long COVID and ME/CFS.
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
The new “prime” and “spike” approach may help prevent breakthrough infections of vaccinated individuals by bolstering immune response within the mucosal lining of the respiratory tract, which are the first cells attacked by COVID-19.Source: YaleNews
The Answer to Stopping the Coronavirus May Be Up the Nose
The Covid-19 vaccines authorized for use today were developed at unprecedented speed and surpassed expectations in how well they worked. The billions of people who are protected by them have avoided severe symptoms, hospitalization and deaths. These vaccines are a scientific success beyond measure. And yet they could be even better.Source: The New York Times
Long COVID deep dive, Part 2: ‘I hope someone with the power to change something is listening’
On this episode of Next Question with Katie Couric, Katie unpacks the systemic issues that are impeding patients’ care and conveys the urgent needs of the long COVID community to elected officials.Source: Next Question with Katie Couric
Long COVID deep dive, Part 1: ‘You need to grieve the life you thought you were going to live’
On this episode of Next Question with Katie Couric — part 1 of a two-part series — Katie attempts to understand long COVID — what it is, what it can do to the body, who is affected, and how it is upending lives.Source: Next Question with Katie Couric
Sex-specific Immune Response in COVID-19 Linked to Cellular Metabolism
Researchers studying COVID-19 patients have found a metabolic pathway that is highly correlated with immune responses only in male patients, a group known to be more likely to suffer severe cases and die of the disease, representing a potential target for therapeutic intervention.Source: Yale News